Nieuws

ADA 2019

Twitter

#ADA2019 offered plenty of news from the technology front—both studies about emerging products and updates on those already on the market #diabetes
https://t.co/BrwiH96dnK

#Free to read with reg (also free) until Tues June 18
Efficacy and safety of oral #semaglutide in patients with type 2 #diabetes and moderate #renal impairment (#PIONEER 5): a placebo-controlled, randomised, phase 3a trial https://t.co/WC2amDbJ1J #T2D

Digital Ten - Digital health news you need to know #ADA2019 #digitaltech #digitalhealth #telehealth #diabetes #dialysis #depression #quitsmoking #migraine #respiratorydisease #healthapps #digitaltherapeutics https://t.co/Th40JllNBn

Uw Mening

  • We horen graag uw mening over Diabetesgeneeskunde.nl. Mist u bijvoorbeeld informatie of heeft u opmerkingen over de website? U kunt ook inhoudelijk bijdragen. Stuur ons uw feedback.